Fan Leilei, Ding Xue
Department of Cardiovascular, Yellow River Central Hospital, Zhengzhou, 450004, People's Republic of China.
Department of Medical, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
J Multidiscip Healthc. 2023 Sep 22;16:2863-2872. doi: 10.2147/JMDH.S424078. eCollection 2023.
Coronavirus disease 2019 is a "Public Health Emergency of International Concern" from 30 January 2020 to 5 May 2023. While battling Coronavirus disease 2019, the Chinese government has actively promoted the collaborative treatment model of Western medicine and traditional Chinese medicine, and clinical and scientific research has applied appropriate and rigorous methodology. Severe acute respiratory syndrome coronavirus 2 infection may damage the cardiovascular system via an unclarified pathogenic mechanism. The National Health Commission of China recommends 'three formulas and three medicines' for the treatment of coronavirus disease 2019, which have been shown to be most effective in the treatments. Data from randomized controlled trials of 'three formulas and three medicines' suggested that the traditional Chinese medicine is safe and can alleviate the symptoms of cardiac injury. Therefore, we further evaluate the benefits and safety of traditional Chinese medicine treatment for Coronavirus disease 2019 patients with cardiac injury across the care continuum.
2020年1月30日至2023年5月5日期间，2019冠状病毒病属于“国际关注的突发公共卫生事件”。在抗击2019冠状病毒病的过程中，中国政府积极推广中西医结合的治疗模式，临床和科研均采用了恰当且严谨的方法。严重急性呼吸综合征冠状病毒2感染可能通过不明致病机制损害心血管系统。中国国家卫生健康委员会推荐用“三方三药”治疗2019冠状病毒病，事实证明这些药物在治疗中最为有效。“三方三药”随机对照试验的数据表明，中药是安全的，并且可以缓解心脏损伤症状。因此，我们进一步评估了在整个护理过程中，中药治疗对伴有心脏损伤的2019冠状病毒病患者的益处和安全性。
